studyselling

154 results found.

Top Stocks matching your search for "study selling"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
PALI

Palisade Bio Inc

-19.56%

$2.25 - $1.81

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 2, 2023

They voluntarily suspended phase 3 bc they are see... See more

Dec, 16, 2022

$PALI phase 2 coming WOOOOO!! !

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
PHVS

Pharvaris NV

-30.10%

$9.60 - $6.71

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Dec, 10, 2022

$PHAR Good news for competitor Pharvaris $PHVS, ... See more

Dec, 9, 2022

$PHVS Look at this company, this could be Athenex ... See more

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
SLRX

Salarius Pharmaceuticals Inc

-8.52%

$2.23 - $2.04

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 20, 2023

watch $gns $slrx $nflx $hlbz LONG AND STRONG $VT... See more

Oct, 28, 2022

$SLRX SP-3164 showed significant tumor growth &q... See more

PALI

Palisade Bio Inc

-19.56%

$2.25 - $1.81

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 2, 2023

They voluntarily suspended phase 3 bc they are seeing such a good results.

Dec, 16, 2022

$PALI phase 2 coming WOOOOO!! !

Nov, 22, 2022

$PALI approaching alpha Centauri phase 🪐

PHVS

Pharvaris NV

-30.10%

$9.60 - $6.71

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Dec, 10, 2022

$PHAR Good news for competitor Pharvaris $PHVS, published interim results of the oral on demand threatment Phase II study which are good!

Dec, 9, 2022

$PHVS Look at this company, this could be Athenex in 2 weeks.. this went up 400% in one day on positive phase 2 data.

Dec, 9, 2022

$LXRX $PHVS goes up 340% on phase 1/2 top line read out

Dec, 9, 2022

$PHVS Trials blocked in US with drug on clinical hold and this goes up 340%.

Dec, 9, 2022

this stock was forever doing nothing languishing at a range of $2 to $3 then all of a sudden, they announce great clinical results and BAMM the stock goes up 339% in ONE DAY!! .

Dec, 8, 2022

That’s how these successful trials run %wise.

Dec, 8, 2022

460k float, amazing news on trial commencement

Dec, 8, 2022

$PHVS what a run on phase 2 results, good short here

SLRX

Salarius Pharmaceuticals Inc

-8.52%

$2.23 - $2.04

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 20, 2023

watch $gns $slrx $nflx $hlbz LONG AND STRONG $VTVT *News about the start of TTP399 phase 3 any day from now When it finally happens after many years the stock will skyrocket

Oct, 28, 2022

$SLRX SP-3164 showed significant tumor growth "inhibition" in in vivo studies including statistically significant improvement over the approved immunomodulatory drugs lenalidomide (Revlimid®) and pomalidomide (Pomalyst®)